No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹300.6Prev. Close
₹300.35Turnover(Lac.)
₹50.26Day's High
₹302.95Day's Low
₹28552 Week's High
₹33052 Week's Low
₹248.85Book Value
₹143.66Face Value
₹5Mkt Cap (₹ Cr.)
849.53P/E
12.05EPS
24.98Divi. Yield
0.82No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 14.45 | 14.16 | 14.14 | 14.13 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 365.37 | 299.79 | 321.63 | 381.55 |
Net Worth | 379.82 | 313.95 | 335.77 | 395.68 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Revenue | 387.96 | 372.82 | 299.26 | 19.35 |
yoy growth (%) | 4.06 | 24.57 | 1,446.28 | 54.73 |
Raw materials | -144.19 | -123.64 | -82.67 | 0 |
As % of sales | 37.16 | 33.16 | 27.62 | 0 |
Employee costs | -59.36 | -57.49 | -50.03 | -5.67 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Profit before tax | 42.56 | 63.22 | 47.54 | -25.64 |
Depreciation | -23.67 | -19.03 | -14.93 | -3.78 |
Tax paid | -12.32 | -11.26 | 16.12 | 22.97 |
Working capital | 15.97 | 18.66 | 5.68 | 214.15 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 4.06 | 24.57 | 1,446.28 | 54.73 |
Op profit growth | -18.97 | 34.86 | -1,216.24 | -33.65 |
EBIT growth | -26.46 | 21.59 | -790.19 | -24.49 |
Net profit growth | -41.81 | -18.37 | -2,484.03 | -88.94 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 469.48 | 335.66 | 349.94 | 398.52 | 377.29 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 469.48 | 335.66 | 349.94 | 398.52 | 377.29 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 11.82 | 11.81 | 8.6 | 8.14 | 8.25 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,847.9 | 100.85 | 4,40,134.01 | 705.44 | 0.87 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,710.5 | 69.14 | 1,77,883.86 | 598 | 0.45 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,380.8 | 66.05 | 1,47,526.68 | 577 | 0.14 | 2,547 | 249.82 |
Lupin Ltd LUPIN | 2,379.5 | 20.34 | 1,12,463.67 | 2,163.69 | 0.49 | 5,152.26 | 595.44 |
Cipla Ltd CIPLA | 1,347 | 24.03 | 1,10,088.66 | 616.88 | 1.17 | 4,256.93 | 411.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
Satish Varma
Company Sec. & Compli. Officer
Srikant N Sharma
Executive Vice Chairman
Krishna Datla
Non Executive Director
Rajeshwari Datla
Executive Director
ANUPAMA DATLA DESAI
Independent Director
Rajashri Santosh Kumar Ojha
Managing Director
Prashant Nagre
Independent Director
Pramod Kasat
Chairman & Independent Director
Pradeep Manjunath Chandan
Independent Director
Ramanand Mundkur
A-1501 DIL Complex Majiwada,
Ghodbunder Road Thane One,
Maharashtra - 400610
Tel: 91-22-66230800/888
Website: http://www.fermentabiotech.com
Email: srikant.sharma@dil.net; contact@dil.net
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Fermenta Biotech Limited was formerly incorporated as Duphar-Interfran Limited in May, 1951. The Company name was changed to DIL Limited in September, 2003 and later on, was changed to Fermenta Biotec...
Read More
Reports by Fermenta Biotech Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.